Latanoprostene Bunod

CAS 1426183-47-7 7 FDA-DMF suppliersSmall Molecule

Overview

Latanoprostene bunod is a prostaglandin analog used topically in the management of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It is a nitric oxide-donating prodrug of latanoprost, which primarily works by remodeling the trabecular meshwork to enhance aqueous humor outflow.

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Latanoprostene Bunod expires 21 Feb 2029. Generic API sourcing typically opens up once these lapse.

Therapeutic areas

Ophthalmology

Related APIs

Levofloxacin
27 suppliers
Latanoprost
22 suppliers
Bimatoprost
15 suppliers
Travoprost
15 suppliers
Timolol Maleate
13 suppliers
Brimonidine Tartrate
11 suppliers
Acetazolamide
11 suppliers
Clonidine Hydrochloride
10 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo